Guido Martignoni

19.3k citations

275 papers · 12.3k indexed · 2 hit papers · h-index 64

Impact in

Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
Cancer Research top 0.5%
- Cancer Genomics and Diagnostics

Papers in

Pulmonary and Respiratory Medicine 170
- Renal cell carcinoma treatment 126
Cancer Research 69
- Cancer Genomics and Diagnostics 59

Co-authors: Matteo Brunelli Maurizio Pea Franco Bonetti Giuseppe Zamboni John N. Eble Liang Cheng Walter Artibani Giacomo Novara
Journals: Modern Pathology (31 papers)The American Journal of Surgical Pathology (17 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (14 papers)Pathology (13 papers)Archives of Pathology & Laboratory Medicine (9 papers)
Partner nations: Italy United States New Zealand

In The Last Decade

Guido Martignoni

272 papers receiving 12.1k citations

Hit Papers

align trajectories log scale

Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity 2014 · 393 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 European Urology
2013 The American Journal of Surgical Pathology

Peers

Countries citing papers authored by Guido Martignoni

Since Specialization

Citations

This map shows the geographic impact of Guido Martignoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Martignoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Martignoni more than expected).

Fields of papers citing papers by Guido Martignoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Martignoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Martignoni. The network helps show where Guido Martignoni may publish in the future.

Co-authors

The 25 scholars most cited alongside Guido Martignoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guido Martignoni Line = papers co-authored together Guido Martignoni links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma Pancreatology ·Quoc Riccardo Bao, Isabella Frigerio, Marzia Tripepi, Stefano Marletta, Guido Martignoni, Alessandro Giardino, Paolo Regi, F. Scopelliti, Valentina Allegrini, R. Girelli, Salvatore Pucciarelli, Gaya Spolverato, Giovanni Butturini	2023	1
2	Carcinoma of Unknown Primary Site With Papillary Renal Cell Carcinoma Features and Without a Kidney Primary Lesion: A Diagnostic and Therapeutic Challenge Urology ·Alessandro Ginori, Luigi Spagnoli, Paola Pacetti, Guido Martignoni, Andrea Cavazzana	2022	1
3	CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients Cells ·Crescenzo D’Alterio, Alessandro Giardino, Giosuè Scognamiglio, Giovanni Butturini, Luigi Portella, Giuseppe Guardascione, Isabella Frigerio, Marco Montella, Stefano Gobbo, Guido Martignoni, Vincenzo Napolitano, Ferdinando De Vita, Fabiana Tatangelo, Renato Franco, Stefania Scala	2022	8
4	Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis Diagnostics ·Francesca Giunchi, Tania Franceschini, Elisa Gruppioni, Annalisa Altimari, Elisa Capizzi, Francesco Massari, Riccardo Schiavina, Matteo Brunelli, Guido Martignoni, Michelangelo Fiorentino	2020	3
5	Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR) Histopathology ·Brett Delahunt, John R. Srigley, Meagan Judge, Mahul B. Amin, Athanase Billis, Philippe Camparo, Andrew Evans, Stewart Fleming, David F. Griffiths, Antonio López-Beltrán, Guido Martignoni, Holger Moch, John N. Nacey, Ming Zhou	2018	13
6	High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment Modern Pathology ·Erik Kouba, John N. Eble, Novae B. Simper, David J. Grignon, Ming‐Sheng Wang, Shaobo Zhang, Lisha Wang, Guido Martignoni, Sean R. Williamson, Matteo Brunelli, Claudio Luchini, Anna Caliò, Liang Cheng	2016	7
7	LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs International Journal of Clinical and Experimental Pathology ·Claudia Fiorini, Matteo Brunelli, Luca Cima, Albino Eccher, Luigino Boschiero, Amedeo Carraro, Gianluigi Zaza, Walter Artibani, Antonio Benito Porcaro, Giovanni Cacciamani, Umberto Tedeschi, Umberto Montin, Paola Violi, Claudio Ghimenton, Giulia Burato, Roberto Iacovelli, Serena Pedron, Marco Chilosi, Guido Martignoni	2016	1
8	T1 high-grade bladder carcinoma outcome: the role of p16, topoisomerase-II α , survivin, and E-cadherin Human Pathology ·Maria Rosaria Raspollini, Rafael J. Luque, Carmen L. Menéndez, Enrico Bollito, Matteo Brunelli, Guido Martignoni, Rodolfo Montironi, Liang Cheng, Ana Blanca, Gianna Baroni, Andrea Minervini, Antonio López-Beltrán	2016	26
9	Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder PMC ·Francesco Massari, Emilio Bria, Chiara Ciccarese, Enrico Munari, Alessandra Modena, Valentina Zambonin, Isabella Sperduti, Walter Artibani, Liang Cheng, Guido Martignoni, Giampaolo Tortora, Matteo Brunelli	2015	3
10	The route to personalized medicine in bladder cancer: where do we stand? Targeted Oncology ·Francesco Massari, Chiara Ciccarese, Matteo Santoni, Matteo Brunelli, Alessandro Conti, Alessandra Modena, Rodolfo Montironi, Daniele Santini, Liang Cheng, Guido Martignoni, Stefano Cascinu, Giampaolo Tortora	2015	14
11	Immunohistochemical expression of [beta]III-tubulin and cell-cell adhesion proteins in papillary thyroid carcinoma: a preliminary report 15th International & 14th European Congress of Endocrinology ·Chiara Colato, Fabio Monzani, Paolo Brazzarola, Guido Martignoni, Marco Chilosi, M Ferdeghini	2012	2
12	Renal Cell Carcinoma With Clear Cell and Papillary Features Archives of Pathology & Laboratory Medicine ·Hillary Ross, Guido Martignoni, Pedram Argani	2012	69
13	Classical lobular breast carcinoma consistently lacks topoisomerase‐IIα gene amplification: implications for the tailored use of anthracycline‐based chemotherapies Histopathology ·Eleonora Brunello, Matteo Brunelli, Erminia Manfrin, Alessia Nottegar, Samantha Bersani, Marco Vergine, Annamaria Molino, Elena Fiorio, Marco Chilosi, Stefano Gobbo, Guido Martignoni, Franco Bonetti	2011	11
14	Her‐2/neu evaluation in Sister Mary Joseph’s nodule from breast carcinoma: a case report and review of the literature Journal of Cutaneous Pathology ·Matteo Brunelli, Erminia Manfrin, Keith Miller, Albino Eccher, Stefano Gobbo, Daniela Reghellin, Marco Chilosi, Andrea Remo, Guido Martignoni, Fabio Menestrina, Franco Bonetti	2009	5
15	Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification American Journal of Clinical Pathology ·Matteo Brunelli, Erminia Manfrin, Guido Martignoni, Keith Miller, Andrea Remo, Daniela Reghellin, Samantha Bersani, Stefano Gobbo, Albino Eccher, Marco Chilosi, Franco Bonetti	2009	87
16	Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis Modern Pathology ·Paolo Cossu‐Rocca, John N. Eble, Shaobo Zhang, Stephen M. Bonsib, Guido Martignoni, Matteo Brunelli, Liang Cheng	2008	20
17	Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma Modern Pathology ·Matteo Brunelli, Albino Eccher, Stefano Gobbo, Vincenzo Ficarra, Giacomo Novara, Paolo Cossu‐Rocca, Franco Bonetti, Fabio Menestrina, Liang Cheng, John N. Eble, Guido Martignoni	2007	70
18	Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases. Archives of Pathology & Laboratory Medicine ·Guido Martignoni, Maurizio Pea, Franco Bonetti, Matteo Brunelli, John N. Eble	2002	43
19	HMB-45: A Review Applied Immunohistochemistry ·Carlos E. Bacchi, Franco Bonetti, Maurizio Pea, Guido Martignoni, Allen M. Gown	1996	47
20	Clear Cell “Sugar” Tumor of the Pancreas The American Journal of Surgical Pathology ·Giuseppe Zamboni, Maurizio Pea, Guido Martignoni, Carlo Zancanaro, Giuseppe Faccioli, Eliana Gilioli, Paolo Pederzoli, Franco Bonetti	1996	283

About Guido Martignoni

Guido Martignoni is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Urology and Physiology, having authored 275 papers that have together received 12.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (126 papers), Renal and related cancers (106 papers), Cancer Genomics and Diagnostics (59 papers), Tuberous Sclerosis Complex Research (48 papers), Bladder and Urothelial Cancer Treatments (29 papers), Urinary and Genital Oncology Studies (17 papers), Vascular Tumors and Angiosarcomas (16 papers) and Urological Disorders and Treatments (14 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.0k citations), Cancer Research (2.6k citations), Oncology (3.3k citations), Physiology (3.1k citations) and Rheumatology (1.3k citations). Guido Martignoni has collaborated with scholars based in Italy, United States and New Zealand. Frequent co-authors include Matteo Brunelli, Maurizio Pea, Franco Bonetti, Giuseppe Zamboni, John N. Eble, Liang Cheng, Walter Artibani, Giacomo Novara, Vincenzo Ficarra and Stefano Gobbo. Their work appears in journals such as Modern Pathology, The American Journal of Surgical Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Pathology and Archives of Pathology & Laboratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact